Third Times The Charm? Radius Recharges IPO After Two Week Hiatus

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Apparently, the chilly market conditions that derailed Radius Health’s IPO a few weeks ago have warmed up. Just 12 days after postponing a $75 million IPO—the second time it has pulled a stock offering since 2012—the Cambridge, MA-based company late Wednesday stepped back into the queue once again. Radius still has the same underwriters—Cowen & Co., Jefferies, Canaccord Genuity, and Cantor Fitzgerald—and would trade on the Nasdaq under the ticker symbol “RDUS” should it finally go public.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC